NIROSHA GNANASSEGARANE: Open Payments
NPI 1245979814 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $140 |
| ABIOMED | 1 | $26 |
| SANOFI PASTEUR INC. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: KISUNLA, MOUNJARO, FLUZONE HIGH-DOSE, AMVUTTRA, Kerendia.
Industry payments across CA — which companies pay providers there.
